‘Unviable’: 450,000 Australians to miss out on subsidised weight loss drug
Pharmaceutical giant Eli Lilly on Friday declined a recommendation to have the government subsidise its Mounjaro drug for Australians with Type 2 diabetes.
Pharmaceutical giant Eli Lilly on Friday declined a recommendation to have the government subsidise its Mounjaro drug for Australians with Type 2 diabetes.